| PERIOD ENDING | 28-Mar-09 | 3-Jan-09 | 6-Sep-08 | 14-Jun-08 | | Total Revenue | 9,236,400 | 13,815,900 | 10,169,300 | 10,120,000 | | Cost of Revenue | 6,583,500 | 9,840,200 | 7,373,700 | 7,254,800 | | | Gross Profit | 2,652,900 | 3,975,700 | 2,795,600 | 2,865,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,371,400 | 3,362,800 | 2,409,300 | 2,413,600 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 281,500 | 612,900 | 386,300 | 451,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,200 | 3,300 | 5,700 | 2,000 | | Earnings Before Interest And Taxes | 282,700 | 616,200 | 392,000 | 453,600 | | Interest Expense | 78,200 | 112,500 | 80,000 | 81,700 | | Income Before Tax | 204,500 | 503,700 | 312,000 | 371,900 | | Income Tax Expense | 60,300 | 165,800 | 112,300 | 137,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 144,200 | 337,900 | 199,700 | 234,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 144,200 | 337,900 | 199,700 | 234,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $144,200 | $337,900 | $199,700 | $234,300 |
|
0.45% Nasdaq 
0.20%
Income Statement
